Insulia Uses Technology to Help People with Type 2 Diabetes Better Manage Insulin

Managing type 2 diabetes is challenging and complex. Despite effective medications that are available, there are multiple factors that influence blood sugar levels, including diet, exercise, and stress levels, and many people with type 2 diabetes do not meet their recommended targets to control their blood sugar. The cost of uncontrolled blood sugar is high, raising the risk of complications from type 2 diabetes that impacts the individual, their family and society.

A new prescription-only medical device is looking to make a positive impact on managing type 2 diabetes: Insulia® Diabetes Management Companion. Insulia provides patients with insulin dose recommendations and educational coaching messages in real-time response to their blood glucose values. The application lives on a patient’s phone or tablet (Android or iOS) or is accessible via a web portal. Insulia also interfaces with the patient’s physician, who initially sets up the personalized treatment plan based on the individual’s needs and who can see the patient’s data remotely to monitor their progress. Insulia provides physicians the ability to deliver highly personalized telemedicine services.

Insulia was launched in the U.S. in July and has received FDA clearance, as well as the European equivalent with the CE mark. Currently, they integrate with insulins Lantus®, Levemir®, and Toujeo® (insulin glargine U-300), and they are working to include all basal insulins and insulin combinations to help as many people with type 2 diabetes as possible.1

Features of Insulia

Insulia uses blood glucose readings and any symptoms of hypoglycemia (low blood sugar) to provide automated recommendations for basal insulin dosing. Some of the features of Insulia include:

  • Data collection – the patient can easily add their blood sugar checks, symptoms of hypoglycemia, and insulin doses
  • Dose explanations – each recommended dose comes with an explanation describing how the calculation was determined
  • Charts – graphs show how the individual’s blood sugar is managed over time
  • Treatment plan – the patient can access their doctor’s recommended treatment plan
  • Support – the app provides educational coaching and allows the individual’s healthcare team to monitor progress.2

About the company behind Insulia

Insulia is made by Voluntis, a company that focuses on therapeutic companion software that helps patients self-manage chronic diseases. All of the patient data is kept secure and private through Voluntis’ technology platform.
Voluntis is headquartered in Paris, France and has a U.S. office in Cambridge, MA.1

View References

Comments

Poll